Cargando…
Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2
The rising incidence of antibiotic-resistant lung infections has instigated a much-needed search for new therapeutic strategies. One proposed strategy is the use of exogenous surfactants to deliver antimicrobial peptides (AMPs), like CATH-2, to infected regions of the lung. CATH-2 can kill bacteria...
Autores principales: | Baer, Brandon, Veldhuizen, Edwin J. A., Molchanova, Natalia, Jekhmane, Shehrazade, Weingarth, Markus, Jenssen, Håvard, Lin, Jennifer S., Barron, Annelise E., Yamashita, Cory, Veldhuizen, Ruud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287084/ https://www.ncbi.nlm.nih.gov/pubmed/32523049 http://dx.doi.org/10.1038/s41598-020-66448-1 |
Ejemplares similares
-
Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
por: Baer, Brandon, et al.
Publicado: (2020) -
The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens
por: Banaschewski, Brandon J. H., et al.
Publicado: (2017) -
Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation In Vivo
por: Coorens, Maarten, et al.
Publicado: (2017) -
The immunomodulatory effect of cathelicidin-B1 on chicken macrophages
por: Peng, Lianci, et al.
Publicado: (2020) -
Towards the Native Binding Modes of Antibiotics that Target Lipid II
por: Medeiros‐Silva, João, et al.
Publicado: (2019)